Heterologous Prime-boost of SARS-CoV-2 inactivated vaccine and mRNA BNT162b2 among Healthy Thai Adolescents

Heterologous Prime-boost of SARS-CoV-2 inactivated vaccine and mRNA BNT162b2 among Healthy Thai Adolescents

Background: Heterologous prime-boost SARS-CoV-2 vaccination is a widely accepted strategy during the COVID-19 pandemic, which generated a superior immune response than homologous vaccination strategy. Objective: To describe immunogenicity of heterologous prime-boost vaccination with inactivated vacc...

Full description

Bibliographic Details
Main Authors: Thanyawee Puthanakit, Rapisa Nantanee, Peera Jaru-Ampornpan, Napaporn Chantasrisawad, Jiratchaya Sophonphan, Thutsanun Meepuksom, Thidarat Jupimai, Pimpayao Sodsai, Suvaporn Anugulruengkitt, Nattiya Hirankarn
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Vaccine: X
Subjects:
SARS-CoV-2 vaccine
Adolescent
Neutralizing antibody titer
Anti-SARS-CoV-2 IgG
CoronaVac vaccine
BNT162b2 vaccine
Online Access:http://www.sciencedirect.com/science/article/pii/S2590136222000717

Internet

http://www.sciencedirect.com/science/article/pii/S2590136222000717

Similar Items